You are here

Magstim

Magstim is the Brains behind TMS. Magstim pioneered Transcranial Magnetic Stimulation technology over 25 years ago. In 2019, Magstim received FDA clearance for StimGuide, the first TMS navigation system developed specifically for the clinical setting. StimGuide provides simple, precise and consistent coil positioning using 4 parameters to guide you to your specific target. Also in 2019, Magstim received 510k clearance for the iTBS 3-minute protocol. In 2018, Magstim received FDA clearance for the Horizon Performance System, our next generation TMS Therapy offering, which features the Energy Recovery System, (ERS). The proprietary ERS software ensures consistent stimulation throughout a treatment with no pulse decay. Horizon is cleared for the 3-minute, 19-minute and 37.5 minute protocols and is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Magstim received its initial FDA 510 (k) clearance to market the Rapid2 Therapy System in 2015.